MAGN:RUSMMK Analysis

Magnera trades around $11.10, just above its technical support of $10.90 and well below its 20‑day SMA of 12.75 and 50‑day SMA of 13.67, indicating a bearish medium‑term trend. The RSI of 26 signals oversold conditions, while the MACD remains in a bearish configuration, suggesting limited upside momentum in the near term. The stock’s beta of 1.68 and 30‑day volatility of 43% point to pronounced price swings, and a historic max drawdown of nearly 60% underscores the downside risk. Fundamentally, the company carries a heavy debt load (debt‑to‑equity ~192%) and a negative profit margin, but it posted $792 million in Q1 revenue with a 12.8% growth rate and an adjusted EBITDA of $93 million, showing operational improvement.
The DCF model values MAGN at roughly $66 per share, implying an upside of over 57% from the current price, while valuation multiples (P/B 0.38, P/S 0.12) are extremely cheap. No dividend is paid, and cash balances are modest relative to debt. The consumer‑defensive sector offers some stability, yet the company’s high leverage and negative ROE keep risk elevated. In sum, the stock appears deeply undervalued on a long‑run basis, but short‑term price action may remain constrained by technical weakness and balance‑sheet concerns.